Document is current
Any future updates will be listed below
-
Authors
Lafrance, Adele
Spriggs, Meg J.
Gukasyan, Natalie
Peck, Stephanie Knatz
- License Information
-
More Information
Article History
Received: 6 August 2024
Accepted: 15 September 2024
First Online: 30 September 2024
Declarations
:
: All above referenced studies conducted by the authors were reviewed and approved by institutional review boards.
: Stephanie Knatz Peck is a paid clinical consultant for Compass Pathways. Natalie Gukasyan was a co-investigator on a study of psilocybin for depression funded by Usona Institute.
